TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.

Daniel Umbricht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.